Amanda Barrett
Psychiatric/Mental Health · Houston, TXNPI 1346609583
Payments from drug & device makers
Across 470 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Lundbeck LLC$809
- Supernus Pharmaceuticals, Inc.$668
- Otsuka America Pharmaceutical, Inc.$658
- Sunovion Pharmaceuticals Inc.$458
- plus $3K from 26 others
What the payments were for
- Food & beverage$8,241100%
- Education$410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 111 | $1,636 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 60 | $1,016 |
| Lundbeck LLC | 37 | $809 |
| Supernus Pharmaceuticals, Inc. | 38 | $668 |
| Otsuka America Pharmaceutical, Inc. | 34 | $658 |
| Sunovion Pharmaceuticals Inc. | 40 | $458 |
| Corium, LLC | 16 | $334 |
| Almatica Pharma LLC | 19 | $314 |
| Teva Pharmaceuticals USA, Inc. | 15 | $301 |
| Ironshore Pharmaceuticals Inc. | 14 | $242 |
| Johnson & Johnson | 10 | $212 |
| Alkermes, Inc. | 8 | $191 |
| Neos Therapeutics, LP | 9 | $153 |
| Axsome Therapeutics, Inc. | 7 | $149 |
| Vanda Pharmaceuticals Inc. | 8 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $119 |
| Livanova USA, Inc. | 4 | $114 |
| Noven Therapeutics, LLC | 6 | $104 |
| Neurocrine Biosciences, Inc. | 4 | $89 |
| Collegium Pharmaceutical, Inc. | 4 | $86 |
| Abbott | 1 | $84 |
| E.r. Squibb & Sons, L.L.C. | 2 | $67 |
| Eisai Inc. | 3 | $62 |
| Bausch Health US, LLC | 3 | $57 |
| Jazz Pharmaceuticals Inc. | 2 | $53 |
| Merck | 2 | $33 |
| Sage Therapeutics, LLC | 1 | $27 |
| OWP Pharmaceuticals, Inc. | 2 | $25 |
| Tempus AI, Inc | 1 | $25 |
| Biogen | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$174
How this compares
$8,282 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 19 | $13 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Houston
- Natalie TellezHouston$602K
- Britney PridgenHouston$57K
- Linzi LeightonHouston$16K
- Samantha SharpeHouston$14K
- Jennifer RobinsonHouston$12K
- Tracy HicksLongview$684K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.